TrialAdvances in therapy2020

Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial.

Gaoxing Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.